[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353571-105":59,"doc-detail-353571-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","nicotinamide-n-methyl-transferase-nnmt-sustains-innate-sensitivity-to-nampt-inhibition-in-yap-dependent-stem-likemesenchymal-prostate-cancer","Nicotinamide N-Methyl Transferase (NNMT) Sustains Innate Sensitivity to NAMPT Inhibition in YAP-dependent Stem-like/Mesenchymal Prostate Cancer","","Nicotinamide phosphoribosyltransferase (NAMPT) functions as the rate-limiting enzyme of the NAD+ salvage pathway and is a promising anticancer target, yet resistance to NAMPT inhibitors such as FK866 limits clinical translation. While acquired resistance has been studied, innate resistance mechanisms remain poorly defined, restricting identification of responsive patient subgroups. This study delineates the YAP/NNMT axis as a regulator of innate FK866 sensitivity in stem-like mesenchymal CRPC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nicotinamide-n-methyl-transferase-nnmt-sustains-innate-sensitivity-to-nampt-inhibition-in-yap-dependent-stem-likemesenchymal-prostate-cancer/353571/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nicotinamide-n-methyl-transferase-nnmt-sustains-innate-sensitivity-to-nampt-inhibition-in-yap-dependent-stem-likemesenchymal-prostate-cancer/353571.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are NAMPT inhibitors like FK866 limited in clinical translation?","Question",{"text":113,"@type":114},"Resistance to NAMPT inhibitors remains a key limitation. The document notes that both acquired and innate resistance mechanisms can reduce therapeutic effectiveness.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What defines stem-like mesenchymal CRPC in this research?",{"text":118,"@type":114},"Stem cell-like CRPC is described as independent from androgen receptor (AR) signaling, dependent on YAP/TAZ, and exhibiting mesenchymal traits.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the YAP/NNMT axis influence sensitivity to FK866?",{"text":122,"@type":114},"The study reports that YAP or NNMT silencing rescues cells from FK866-induced apoptosis, ER stress, and NAD(H) depletion. Metabolomic data indicate NNMT activity depletes nicotinamide and sensitizes cells to FK866.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353571,1790172976,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2026; 22(3): 1126-1141. doi: 10.7150/ijbs.120532  \nResearch Paper  \nNicotinamide N-Methyl Transferase (NNMT) Sustains Innate Sensitivity to NAMPT Inhibition in YAPdependent Stem-like/Mesenchymal Prostate Cancer  \nÁgata Sofia Assunção Carreira1\\#, Marianna Ciuffreda2, Nathakan Thongon1, Charles M. Haughey3, Adam Pickard3, Sharon L. Eddie3, Rebecca E. Steele3, Elena Cerri1, Romina Belli4, Daniele Peroni4, Elisa Facen1, Irene Caffa5,6, Moustafa Ghanem5, Alessio Nencioni5,6, Andrea Lunardi1, Toma Tebaldi2, Ian G. Mills3,7, Alessandro Provenzani1􀀍  \n1. University of Trento, CIBIO-Laboratory of Genomic Screening, Trento, Italy.  \n2. University of Trento, CIBIO-Laboratory of RNA and Disease Data Science, Trento, Italy.  \n3. Patrick G Johnston Centre for Cancer Research, Queen's University, Belfast BT9 7AE, UK.  \n4. University of Trento, CIBIO-Mass Spectrometry and Proteomics Facility, Trento, Italy.  \n5. Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, 16132 Genoa, Italy.  \n6. Ospedale Policlinico San Martino IRCCS, 16132 Genova, Italy.  \n7. Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.  \n\\# Current address: Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK; [agata.carreira@nds.ox.ac.uk](agata.carreira@nds.ox.ac.uk).  \n􀀍 Corresponding author: Alessandro Provenzani; alessandro.provenzani@unitn.it.  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.06.28; Accepted: 2025.11.14; Published: 2026.01.01  \nAbstract  \nNicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme in the NAD+ salvage pathway and a promising therapeutic target in cancer. Resistance to NAMPT inhibitors, such as FK866, remains a key limitation to their clinical translation. While acquired resistance in cancer cell lines has been linked to target mutations, increased drug efflux, and metabolic reprogramming, innate resistance mechanisms have been poorly studied. Addressing this gap is crucial for identifying patient subgroups that are most likely to benefit from NAMPT-targeted therapies.  \nAdvanced castration resistance prostate cancer (CRPC) lacks effective targeted treatments. Among its heterogeneous subtypes, stem cell-like CRPC (CRPC-SCL) is characterized by independence from androgen receptor (AR) signaling, dependency on YAP/TAZ, and mesenchymal traits. In this study, we identify the YAP/nicotinamide N-methyltransferase (NNMT) axis as a key regulator of innate sensitivity to FK866 in stem-like mesenchymal CRPC cells.  \nUsing genetic and pharmacological models, we show that YAP or NNMT silencing rescues PC3 cells from FK866-induced apoptosis, endoplasmic reticulum stress, and NAD(H) depletion. Metabolomic profiling confirmed that NNMT activity depletes nicotinamide, sensitizing cells to FK866. We further validated NNMT upregulation across clinical CRPC-SCL datasets, where it strongly correlates with mesenchymaland therapy-resistant phenotypes. Murine prostate cancer cells with mesenchymal/stemness phenotypes (DVL3-SCM), that exhibit NNMT overexpression and high aggressiveness in vivo, also show increased sensitivity to FK866 compared with their parental counterparts (DVL3-PAR).  \nIn conclusion, we identify the YAP/NNMT axis as a determinant of innate sensitivity to NAMPT inhibition in prostate cancer. These findings support the use of NNMT as a predictive biomarker for NAD+-targeting therapies and provide mechanistic insight into a metabolic vulnerability of the CRPC-SCL subtype. Targeting the YAP/NNMT/NAMPT axis may represent a novel str","cbCaifRlQu3Wdbzz","https://ap.wps.com/l/cbCaifRlQu3Wdbzz","pdf",3508589,16,"English","# Abstract\n## Key background and rationale\n## Study design and main findings\n## Conclusions and clinical implications","[{\"question\":\"Why are NAMPT inhibitors like FK866 limited in clinical translation?\",\"answer\":\"Resistance to NAMPT inhibitors remains a key limitation. The document notes that both acquired and innate resistance mechanisms can reduce therapeutic effectiveness.\"},{\"question\":\"What defines stem-like mesenchymal CRPC in this research?\",\"answer\":\"Stem cell-like CRPC is described as independent from androgen receptor (AR) signaling, dependent on YAP/TAZ, and exhibiting mesenchymal traits.\"},{\"question\":\"How does the YAP/NNMT axis influence sensitivity to FK866?\",\"answer\":\"The study reports that YAP or NNMT silencing rescues cells from FK866-induced apoptosis, ER stress, and NAD(H) depletion. Metabolomic data indicate NNMT activity depletes nicotinamide and sensitizes cells to FK866.\"}]","Nicotinamide N-Methyl Transferase (NNMT) Sustains Innate Sensitivity to NAMPT Inhibition in YAP-dependent Stem-like/Mesenchymal Prostate Cancer | PDF",1790106091,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29a3a3987d36be4aa2c6f9140e633234.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42f173ed7b08b44f3f78596a557f8942.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0797db53fcc35cda1629a950dfbfa4e1.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/834bb3fdda72c88a85323d51dd4703da.webp",980,1268]